[Swiss clinical practice guidelines for skin cancer in organ transplant recipients]

Lapointe, A-K; Hofbauer, G; Anliker, M; Arnold, A; Binet, I; Hunger, R; Kempf, W; Pascual, M; Pelloni, F; Serra, A; Laffitte, E (2010). [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]. Revue médicale suisse, 6(246), pp. 854-9. Genève: Médecine & Hygiène

Full text not available from this repository. (Request a copy)

Swiss clinical practice guidelines for skin cancer in organ transplant recipients Transplant patients have increased over the last decades. As a consequence of long-term immunosuppression, skin cancer, in particular squamous cell carcinoma (SCC), has become an important problem. Screening and education of potential organ transplant recipients (OTRs) regarding prevention of sun damage and early recognition of skin cancer are important before transplantation. Once transplanted, OTRs should be seen yearly by a dermatologist to ensure compliance with sun avoidance as well as for treatment of precancerosis and SCC. Early removal is the best treatment for SCC. Reduction of immunosuppression, switch to mTOR inhibitors and chemoprevention with acitretin may reduce the incidence of SCC. The dermatological follow-up of OTRs should be integrated into a comprehensive post-transplant management strategy.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ear, Nose and Throat Disorders (ENT)
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Arnold, Andreas Michael, Hunger, Robert




Médecine & Hygiène




Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

05 Dec 2022 14:01

PubMed ID:


Web of Science ID:



https://boris.unibe.ch/id/eprint/2266 (FactScience: 204657)

Actions (login required)

Edit item Edit item
Provide Feedback